Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life.
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan.
Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Newronika Quality Management System ensures proper implementation and effective monitoring of design, development, purchasing, production, marketing, customer communication, and assistance processes. The implementation and maintenance of the Quality Management System represents the way Newronika has worked since the company started. The application of the Quality Management System ensures that the products comply with regulatory and custom requirements.
The Products are designed and manufactured in accordance with the European Directive 93/42/EEC and 90/385 on medical devices and meet the requirements of harmonized standards that apply to them. Requirements set by Canadian MDR and South Korea are also comply with.
The certification of conformity to the ISO 13485 has been released by authorities in the EU, Canada, and South Korea.
Working with us means a dynamic environment, geared towards the future of new technologies in neuromodulation. Our team comprises neurophysiology technicians, biotechnologists, neurologists and neurosurgeons, pshychologists, and engineers. If you are interested in internship or you want to be part of our team, send us your CV.